Prevention of relapse after T-cell depleted allogeneic bone marrow transplantation by preemptive donor leukocyte infusions

被引：0
|
作者：
Schaap, N [1 ]
Schattenberg, A [1 ]
Bär, B [1 ]
Preijers, F [1 ]
de Witte, T [1 ]
机构：
[1] Univ Nijmegen Hosp, Div Hematol, NL-6500 HB Nijmegen, Netherlands
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
148
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [31] Bone Marrow Mixed Chimerism Is a Risk Factor for Relapse After T-Cell Depleted Allogeneic Stem Cell Transplant
    Olson, Amanda L.
    Barker, Juliet N.
    Castro-Malaspina, Hugo
    Devlin, Sean
    Giralt, Sergio A.
    Goldberg, Jenna D.
    Lehrman, Rachel
    Maloy, Molly
    O'Reilly, Richard J.
    Perales, Miguel-Angel
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    BLOOD, 2012, 120 (21)
  • [32] Donor lymphocyte infusions for B-cell malignancies relapse after T-cell replete allogeneic hematopoietic cell transplantation
    Orti, Guillermo
    Garcia-Cadenas, Irene
    Lopez-Corral, Lucia
    Perez, Ariadna
    Jose Jimenez, Maria
    Sanchez-Ortega, Isabel
    Alonso, Laura
    Sisinni, Luisa
    Fox, Laura
    Villacampa, Guillermo
    Badell, Isabel
    Diaz de Heredia, Cristina
    Parody, Rocio
    Ferra, Christelle
    Solano, Carlos
    Caballero, Dolores
    Martino, Rodrigo
    Querol, Sergi
    Valcarcel, David
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1133 - 1137
  • [33] Second bone marrow transplant (2BMT) and donor leukocyte infusions (DLI) to treat relapse or graft failure after allogeneic bone marrow transplantation (BMT).
    VelaOjeda, J
    TrippVillanueva, F
    SanchezCortes, E
    AyalaSanchez, M
    GonzalezLlaven, J
    BLOOD, 1997, 90 (10) : 4479 - 4479
  • [34] Risk factors for CMV reactivation after T-cell depleted allogeneic bone marrow transplantation.
    Lin, TS
    Zahrieh, D
    Weller, E
    Alyea, ER
    Fisher, DC
    Gribben, JG
    Freedman, AS
    Schlossman, RL
    Lee, SJ
    Antin, JH
    Ritz, J
    Soiffer, RJ
    BLOOD, 2001, 98 (11) : 480A - 481A
  • [35] Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions
    Small, TN
    Papadopoulos, EB
    Boulad, F
    Black, P
    Castro-Malaspina, H
    Childs, BH
    Collins, N
    Gillio, A
    George, D
    Jakubowski, A
    Heller, G
    Fazzari, M
    Kernan, N
    MacKinnon, S
    Szabolcs, P
    Young, JW
    O'Reilly, RJ
    BLOOD, 1999, 93 (02) : 467 - 480
  • [36] Allogeneic T-cell depleted blood stem cell transplantation versus T-cell depleted bone marrow transplantation: a prospective randomized multicenter study
    Cornelissen, J
    Verdonck, L
    Van der Holt, B
    Petersen, E
    Schouten, H
    Russel, L
    Vindelov, L
    Hoglund, M
    Maertens, J
    Maertens, J
    Boogaerts, M
    Lowenberg, B
    BONE MARROW TRANSPLANTATION, 2003, 31 : S40 - S40
  • [37] Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation
    Porter, DL
    Roth, MS
    Lee, SJ
    McGarigle, C
    Ferrara, JLM
    Antin, JH
    BONE MARROW TRANSPLANTATION, 1996, 18 (05) : 975 - 980
  • [38] INFECTIOUS COMPLICATIONS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH AND WITHOUT T-CELL DEPLETION OF DONOR MARROW
    SCHMEISER, T
    WIESNETH, M
    BUNJES, D
    ARNOLD, R
    HERTENSTEIN, B
    HEIT, W
    KURRLE, E
    INFECTION, 1989, 17 (03) : 124 - 130
  • [39] Donor leukocyte infusions (DLI) to treat relapses after allogeneic bone marrow transplantation in pediatric patients.
    Levine, JE
    Yanik, G
    Hutchinson, RJ
    Casper, J
    Beatty, PC
    Sproles, A
    Collins, R
    BLOOD, 1997, 90 (10) : 2439 - 2439
  • [40] The first clinical use of donor leukocyte infusions for the treatment of leukemia relapsing after allogeneic bone marrow transplantation
    Mehta, J
    BLOOD, 1996, 87 (09) : 4010 - 4010
12345